Clinical Trials Browser

Triple Negative Breast Neoplasms × axatilimab × 1 year × Clear all

NCT05491226 2025-08-27

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

Phase 2 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms